Skip to content
Home/Companies/MedTech/Hemovent

Hemovent

MedTech·Germany·Exited 2021·Held 5yr
Entry
2016
Hold
5yr
Exit
2021

Who owns Hemovent?

Hemovent was owned by NRW.BANK through NRW.Venture (2006 vintage) from 2016 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-10

NRW.BANK
Investor
NRW.BANK
NRW.Venture · 2006 · VC

Key facts

HQGermany
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from NRW.Venture

Other portfolio companies in the same fund.

JUPUS
Jupus
Active
LegalTechGermany· 2026
clockin
clockin
Active
SaaSGermany· 2025
Disco Pharmaceuticals
Active
BiotechGermany· 2025
eeden
Active
ClimateTechGermany· 2025
iDEL Therapeutics
Active
BiotechGermany· 2025
Lidrotec
Active
Deep TechGermany· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Hemovent

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Hemovent.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue